| Message: | PRL-8-53 (chemical name Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate) is a synthetic nootropic compound discovered in 1972 and patented in 1975 by the late Dr. Nikolaus Hansl, a neuropharmacologist at Creighton University in Omaha, Nebraska. Preliminary animal tests indicated that the compound was both safe and significantly nootropic, boosting avoidance learning in rodents with no adverse effects. But the real interest in PRL-8-53 was sparked by a 1978 study on human volunteers, which showed that a single dose of the compound could improve word retention scores by more than 200%.
Product name PRL-8-53 HCL
Other name PRL-8053;PRL-8-53 hydrochloride;3-(2-(benzyl(methyl)amino)ethyl)benzoate.
PRL-8-53 CAS No. 51352-87-5
PRL-8-53 Molecular formula C18H22ClNO2
PRL-8-53 Molecular weight 319.82578
PRL-8-53 Appearance Off white solid powder
Purity 99%+
PRL-8-53 Packing 50G or as your requirement
What is PRL-8-53?
PRL-8-53 is a hypermnesiac nootropic,a synthetic supplement with potential benefits for short term memory. A single study in humans was reported in 1978. The double-blind trial of PRL-8-53 in 47 healthy volunteers measured its effects on a variety of cognitive measures. 5 mg of the drug was administered orally 2-2.5 hours before the study tasks.[1] Overall improvements in recollection differed based on how many words were recalled under placebo, with the poor performers (six words or fewer) experiencing a 87.5-105% increase in recollection and the high performers (eight or more words) a 7.9-14% increase which failed to reach statistical significance; when controlling for subjects over the age of 30 only, a 108-152% increase was noted No side effects were reported during the trial.
|
my account
